発表論文 - 2026年
- Nakamura Y, Ahagon-Edamura A, Koga R, Shimagaki K, Uesugi M, Fujino H, Beyri B, Arakaki Y, Ciftci H, Masunaga T, Tateishi H, Otsuka M, Yamaguchi Y, and Fujita M.
Regulation of HIV-2 Vpx/Vpr expression by the poly-proline motif: Enhancement of protein dimerization and translation.
Virology, in press.
- Badran MM, Beyri B, Tateishi H, Shimagaki K, Nakata A, Ito A, Nishimura N, Abbas SHH, Abdel-Aziz M, Otsuka M, Yoshida M, Fujita M, Brase S, and Radwan MO.
Harnessing substituted 4-chlorothieno[2,3-b]pyridine as a new cap for potent and selective antiproliferative HDAC inhibitors.
Pharmaceuticals 19: 442, 2026.
- Kato K, Yamaguchi Y, Ichimaru Y, Kajiyama M, Kato M, Nagatomo M, Jin W, Wachino JI, Arakawa Y, Fukuishi N, Fujita M, Otsuka M, and Kurosaki H.
Structure-guided evaluation of thiol-based fluorescent probes for selective detection and inhibition of metallo-β-lactamases.
Biological and Pharmaceutical Bulletin 49: 691-700, 2026.
- Sever B, Turkes C, Demir Y, Elamin KM, Osman W, Oral K, Genc SA, Canturk Z, Masunaga T, Kishimoto N, Misumi S, Otsuka M, Fujita M, and Ciftci H.
Hydrazonylthiazole derivatives as dual EGFR and ALR2 inhibitors: Design, synthesis, and comprehensive in vitro and in silico evaluation for potential anticancer activity.
Pharmaceuticals 19:50, 2026.
